Envista (NVST), a dental platform company formed from Danaher's dental businesses, holds a #3 (Hold) Zacks Rank with a B VGM Score and A Value Style Score. The company features an attractive forward P/E ratio of 14.86 and has demonstrated a +19.4% average earnings surprise, making it a consideration for value-focused investors despite its hold rating.

Zacks Premium offers investment research tools including Style Scores (Value, Growth, Momentum, and VGM) that complement the Zacks Rank system to help investors identify stocks with the best performance potential. The Zacks Rank has historically outperformed the S&P 500 with an average annual return of +23.86% since 1988. Envista (NVST) is highlighted as a stock to watch with a #3 Hold rank and B-rated Growth and VGM Style Scores, forecasting 28.6% year-over-year earnings growth.

Cooper Companies director Paul Keel purchased 4,701 shares worth $250,000 at $53.18 per share on September 11, 2026, following a 21% year-long stock decline. The insider buy is viewed as a bullish signal, suggesting confidence in the company's long-term growth prospects. Keel, who recently joined Cooper's board in May, brings extensive experience from his CEO role at Envista Holdings and prior positions at 3M.

Zacks highlights three stocks with Rank #1 (Strong Buy) ratings and strong value characteristics: Slide Insurance Holdings (SLDE) with a P/E of 6.59 and Value Score A, Howard Hughes Holdings (HHH) with a P/E of 12.68 and Value Score A, and Envista Holdings (NVST) with a P/E of 15.25 and Value Score B. All three have seen recent increases in earnings consensus estimates.

In a comparison of two Medical Products stocks, Envista (NVST) emerges as the superior value option over Abbott (ABT). NVST holds a Zacks Rank #2 (Buy) with a Value grade of B, featuring a lower forward P/E ratio of 17.51 and PEG ratio of 1.28. ABT has a Zacks Rank #3 (Hold) with a Value grade of C, with higher valuations at P/E of 19.11 and PEG of 1.96. Based on stronger earnings outlook and more attractive valuation metrics, NVST is positioned as the better value investment.

DENTSPLY SIRONA (XRAY) exceeded Q2 earnings and revenue estimates with adjusted EPS of 52 cents versus 36 cents consensus, though revenues fell 4.1% year-over-year. The company maintained full-year 2026 guidance of $3.5-3.6B in sales and $1.40-1.50 adjusted EPS. Wellspect Healthcare grew 7.1%, but three dental segments declined, with tariff pressures and lower volumes constraining operating margins. Free cash flow improved to $55M from $16M year-ago.

As the stock market hovers near record levels amid elevated Treasury yields and inflation concerns, Zacks highlights four fundamentally sound companies trading at reasonable valuations using PEG ratio analysis. The featured stocks—Dollar General, Envista, Match Group, and Allstate—offer attractive value opportunities for investors seeking alternatives to high-momentum technology and AI stocks.

The global dental imaging equipment market is projected to expand from USD 3.36 billion in 2026 to USD 4.74 billion by 2031, growing at a 7.1% CAGR. Growth is driven by increased demand for digital and 3D imaging technologies, rising dental disorders, and expanding dental infrastructure, though high capital costs and regulatory challenges remain constraints.

The global dental laboratories market is projected to grow from USD 9.20 billion in 2025 to USD 13.09 billion by 2030, with a CAGR of 7.3%. Growth is driven by rising dental disorders, aging populations, and technological advancements including digital workflows, CAD/CAM systems, and 3D printing. North America leads the market, with CAD/CAM materials dominating the product segment.

The global clear aligners market is valued at $11.23 billion in 2026 and is expected to grow to $99.44 billion by 2034, expanding at a 31.34% CAGR. North America leads the market while Asia Pacific shows the fastest growth. Adults dominate by age segment, polyurethane leads by material type, and online distribution channels are expected to grow fastest. Key drivers include rising demand for aesthetic orthodontic solutions, technological advancements in 3D imaging and AI, and expanding access through digital platforms.

The global dental fillings market is projected to grow from $8.28 billion in 2026 to $13.84 billion by 2032, expanding at a CAGR of 8.65%. Growth is driven by material innovation, digital dentistry integration, advanced restorative solutions, and sustainability initiatives, with key opportunities in aesthetic improvements and regulatory compliance.

The AI-based caries detection market is projected to grow from $0.62 billion in 2025 to $1.11 billion by 2029 at a 15.6% CAGR, driven by rising dental disease prevalence, aging populations, and increased preventive dentistry adoption. Key innovations include VideaHealth's Caries 3 model and partnerships like Dentalcorp's integration of AI detection technology. However, U.S. tariffs and trade tensions are pressuring margins in the medical equipment sector.